Limit by project type:

Limit by country:

With its bottom-up approach, EUREKA supports the development of rapidly marketable innovative products, processes and services that help improve the daily life of everyday people. The commercialisation of the innovative products, processes and services from hundreds of successfully completed projects have added billions of euro to national economies.

Hungarian and Israeli biotech companies teamed up to tackle Crohn’s, an intractable inflammatory bowel disease that affects five million people worldwide. Its causes are uncertain. There is no foolproof cure and poor public understanding of the pain and chronic suffering it causes. But things are looking up thanks to the work of the Eureka PIP-4-CD team.

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.